Clinical Trials

NCT02717455 | COMPLETED | PHASE1

53 participants

Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2016-06-28

Completion:

2022-02-14

Conditions

• Glioma

Interventions

• DRUG

Results Available

NCT02705105 | COMPLETED | PHASE1/PHASE2

114 participants

Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2016-02-29

Completion:

2018-08-22

Conditions

• Solid Tumor
• Cancer
• Carcinoma
• Hepatocellular Carcinoma
• HCC

Interventions

• BIOLOGICAL

Results Available

NCT02698852 | ACTIVE_NOT_RECRUITING | NA

1000 participants

A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2015-12-31

Completion:

2019-05-31

Conditions

• Coronary Artery Disease

Interventions

• DEVICE

No Results Yet

NCT02698839 | ACTIVE_NOT_RECRUITING | NA

539 participants

A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2015-12-31

Completion:

2018-03-31

Conditions

• Coronary Artery Disease

Interventions

• DEVICE

No Results Yet

NCT02610231 | COMPLETED | PHASE3

239 participants

Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2015-12-31

Completion:

2017-12-20

Conditions

• Idiopathic Parkinson's Disease

Interventions

• DRUG

Results Available

NCT02609477 | COMPLETED | PHASE1

42 participants

A Study to Evaluate Abuse Potential of Istradefylline

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2016-01-31

Completion:

2016-07-31

Conditions

• Drug Abuse

Interventions

• DRUG
• OTHER

No Results Yet

NCT02581098 | COMPLETED

98 participants

miR-200b & miR-21 in Diabetic Wounds

Study Type:

OBSERVATIONAL

Last Updated:

2024-04-25

Start Date:

2015-08-31

Completion:

2023-06-26

Conditions

• Diabetes Mellitus
• Foot Ulcer
• Ulcer
• Diabetic Foot Ulcer
• Wound
• Wound Heal

Interventions

• OTHER

No Results Yet

NCT02523898 | TERMINATED | PHASE2

388 participants

Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2015-11-30

Completion:

2022-04-30

Conditions

• Polycystic Ovary Syndrome
• Hyperandrogenism

Interventions

• DRUG

No Results Yet

NCT02360280 | COMPLETED | PHASE2

62 participants

Efficacy of Repeated Ketamine Infusions for Treatment-resistant Depression

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2015-04-01

Completion:

2018-10-22

Conditions

• Treatment-resistant Depression

Interventions

• DRUG

Results Available

NCT02313428 | TERMINATED | NA

4 participants

Topical Oxygen Therapy for Diabetic Wounds

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2020-02-01

Completion:

2021-08-05

Conditions

• Diabetic Foot Ulcers
• Wound

Interventions

• DEVICE

Results Available

NCT02301130 | COMPLETED | PHASE1

64 participants

Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2014-11-26

Completion:

2017-12-08

Conditions

• Advanced Solid Tumors

Interventions

• BIOLOGICAL

No Results Yet

NCT02298400 | WITHDRAWN | NA

0 participants

A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2014-08-31

Completion:

2014-09-30

Conditions

• Contact Lens Complication

Interventions

• DEVICE

No Results Yet

NCT02256033 | COMPLETED | PHASE1

20 participants

Effect of Mild Hepatic Impairment on the Pharmacokinetics of Istradefylline

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2014-08-31

Completion:

2014-12-31

Conditions

• Hepatic Impairment

Interventions

• DRUG

No Results Yet

NCT02248259 | COMPLETED | PHASE1

25 participants

Drug Drug Interaction Trial With Strong CYP3A4 Inhibitor (Itraconazole) in CYP2C19 Extensive Metabolizers and Poor Metabolizers

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2014-10-08

Completion:

2015-01-07

Conditions

• Healthy

Interventions

• DRUG

Results Available

NCT02174250 | COMPLETED | PHASE1

20 participants

The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2014-06-30

Completion:

2014-08-31

Conditions

• Parkinson's Disease

Interventions

• DRUG

No Results Yet

NCT02090140 | RECRUITING | NA

17 participants

Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2015-11-30

Completion:

2025-12-31

Conditions

• Degenerative Lesion of Articular Cartilage of Knee

Interventions

• PROCEDURE

No Results Yet

NCT02030366 | RECRUITING

40 participants

Chromatic Multifocal Pupillometer for Detection and Follow-up of Acute Head Injury

Study Type:

OBSERVATIONAL

Last Updated:

2024-04-25

Start Date:

2015-10-01

Completion:

2025-12-31

Conditions

• Traumatic Brain Injury (TBI) Patients

No Results Yet

NCT02024243 | TERMINATED

54 participants

Role of Tissue Oxygenation and the miR-210 Gene In Wound Healing

Study Type:

OBSERVATIONAL

Last Updated:

2024-04-25

Start Date:

2015-10-01

Completion:

2023-03-08

Conditions

• Non-Diabetic Patients
• Wound Leg
• Chronic Ulcer Leg/Foot

No Results Yet

NCT02014389 | RECRUITING

200 participants

Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer

Study Type:

OBSERVATIONAL

Last Updated:

2024-04-25

Start Date:

2013-12-01

Completion:

2026-12-31

Conditions

• Retinal Dystrophies
• Retinitis Pigmentosa
• Glaucoma

No Results Yet

NCT01968031 | COMPLETED | PHASE3

613 participants

A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2013-10-31

Completion:

2016-10-31

Conditions

• Idiopathic Parkinson's Disease

Interventions

• DRUG

Results Available

NCT01898156 | TERMINATED | PHASE1/PHASE2

37 participants

Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2013-07-31

Completion:

2016-06-30

Conditions

• Phase 1 Portion : Non Small Cell Lung Cancer(NSCLC), Small Cell Lung Cancer(SCLC), Mesothelioma
• Phase 2 Portion : Small Cell Lung Cancer(SCLC)

Interventions

• DRUG

No Results Yet

NCT01892384 | COMPLETED | PHASE1

40 participants

Safety and Tolerability of BI 409306 in Patients With Schizophrenia

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2013-06-28

Completion:

2013-12-05

Conditions

• Schizophrenia

Interventions

• DRUG

Results Available

NCT01728805 | COMPLETED | PHASE3

372 participants

Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2012-11-30

Completion:

2017-03-31

Conditions

• Cutaneous T-Cell Lymphoma

Interventions

• BIOLOGICAL
• DRUG

Results Available

NCT01680510 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

100 participants

The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2012-09-01

Completion:

2025-12-31

Conditions

• Retinitis Pigmentosa

Interventions

• DIETARY_SUPPLEMENT
• OTHER

No Results Yet

NCT01626664 | COMPLETED | PHASE2

71 participants

KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2012-06-30

Completion:

2015-08-31

Conditions

• Adult T-cell Leukemia-Lymphoma

Interventions

• BIOLOGICAL
• DRUG

Results Available

NCT01556659 | TERMINATED | NA

25 participants

LV Thrombus After Acute AMI: A Randomized Controlled Trial

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2012-03-31

Completion:

2018-12-31

Conditions

• Ventricular Thrombosis Mural Following Myocardial Infarction

Interventions

• DRUG

No Results Yet

NCT01343706 | COMPLETED | PHASE1

80 participants

Safety Tolerability and Pharmacokinetic of BI 409306

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2011-04-01

Completion:

2011-08-01

Conditions

• Healthy

Interventions

• DRUG

Results Available

NCT01226472 | COMPLETED | PHASE2

1 participants

Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2010-08-31

Completion:

2012-09-30

Conditions

• Peripheral T-cell Lymphoma
• Cutaneous T-cell Lymphoma

Interventions

• BIOLOGICAL

Results Available

NCT01199367 | TERMINATED | PHASE1

11 participants

Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2010-12-31

Completion:

2012-12-31

Conditions

• Breast Cancer

Interventions

• DRUG

No Results Yet

NCT01101854 | TERMINATED

74 participants

Gene Expression Profiles in Healing and Non-Healing Wounds

Study Type:

OBSERVATIONAL

Last Updated:

2024-04-25

Start Date:

2020-07-30

Completion:

2021-10-23

Conditions

• Wounds and Injuries

No Results Yet

NCT01063907 | COMPLETED | PHASE1/PHASE2

95 participants

A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2010-03-31

Completion:

2013-11-30

Conditions

• Multiple Myeloma

Interventions

• DRUG

Results Available

NCT00955045 | COMPLETED | PHASE2/PHASE3

A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2002-08-31

Completion:

2003-10-31

Conditions

• Parkinson's Disease

Interventions

• DRUG

No Results Yet

NCT00953758 | COMPLETED | PHASE1

47 participants

A Study Of PF-04449913 In Select Hematologic Malignancies

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2010-03-03

Completion:

2012-09-26

Conditions

• Hematologic Malignancies

Interventions

• DRUG

Results Available

NCT00940225 | COMPLETED | PHASE2

730 participants

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2009-09-30

Completion:

2013-05-31

Conditions

• Solid Tumors
• Cancer

Interventions

• DRUG

Results Available

NCT00921336 | COMPLETED | PHASE1

13 participants

Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2009-06-30

Completion:

2010-08-31

Conditions

• Solid Tumor

Interventions

• DRUG

No Results Yet

NCT00888927 | COMPLETED | PHASE1/PHASE2

42 participants

Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2009-05-31

Completion:

2012-09-30

Conditions

• Peripheral T-Cell Lymphoma

Interventions

• BIOLOGICAL

Results Available

NCT00779480 | TERMINATED | PHASE1

14 participants

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002)

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2009-01-31

Completion:

2010-04-30

Conditions

• Acute Myelogenous Leukemia (AML)

Interventions

• DRUG

No Results Yet

NCT00775502 | TERMINATED | PHASE1

23 participants

Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2008-10-31

Completion:

2011-05-31

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT00457782 | COMPLETED | PHASE1

27 participants

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2007-04-30

Completion:

2010-08-31

Conditions

• Multiple Myeloma
• Chronic Lymphocytic Leukaemia
• B-cell Non-Hodgkin's Lymphoma

Interventions

• DRUG

No Results Yet

NCT00456794 | COMPLETED | PHASE2

325 participants

12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa

Study Type:

INTERVENTIONAL

Last Updated:

2024-04-25

Start Date:

2002-03-31

Completion:

2003-10-31

Conditions

• Parkinson's Disease

Interventions

• DRUG

No Results Yet